Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
04 2020
Historique:
received: 16 09 2019
revised: 05 12 2019
accepted: 13 12 2019
pubmed: 24 2 2020
medline: 2 7 2020
entrez: 24 2 2020
Statut: ppublish

Résumé

Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018. We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries. In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries. A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries. WHO; Bill & Melinda Gates Foundation.

Sections du résumé

BACKGROUND
Seasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018.
METHODS
We estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries.
FINDINGS
In 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries.
INTERPRETATION
A large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries.
FUNDING
WHO; Bill & Melinda Gates Foundation.

Identifiants

pubmed: 32087815
pii: S2214-109X(19)30545-5
doi: 10.1016/S2214-109X(19)30545-5
pmc: PMC7083228
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e497-e510

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : CGH CDC HHS
ID : U01 GH001003
Pays : United States

Investigateurs

Harish Nair (H)
Harry Campbell (H)
Xin Wang (X)
You Li (Y)
Alexandria Chung (A)
Manveer Rahi (M)
Qalab Abbas (Q)
Asad Ali (A)
Zulfiqar A Bhutta (ZA)
Bushra Saeed (B)
Sajid B Soofi (SB)
Mohammad Tahir Yousafzai (MT)
Anita K Zaidi (AK)
Alberta Amu (A)
Elizabeth Awini (E)
Eduardo Azziz-Baumgartner (E)
Henry C Baggett (HC)
Sandra S Chaves (SS)
Nong Shang (N)
Stephanie J Schrag (SJ)
Marc-Alain Widdowson (MA)
Stefano Tempia (S)
Quique Bassat (Q)
Miguel Lanaspa (M)
Sozinho Acácio (S)
W Abdullah Brooks (WA)
Amanda Driscoll (A)
Maria Deloria Knoll (MD)
Katherine L O'Brien (KL)
Christine Prosperi (C)
Abdullah H Baqui (AH)
Luke Mullany (L)
Peter Byass (P)
Cheryl Cohen (C)
Anne von Gottberg (A)
Orienka Hellferscee (O)
Florette K Treurnicht (FK)
Sibongile Walaza (S)
Doli Goswami (D)
Mustafizur Rahman (M)
Nicholas E Connor (NE)
Shams El Arifeen (S)
Marcela Echavarria (M)
Débora N Marcone (DN)
Noelia Reyes (N)
Andrea Gutierrez (A)
Ivan Rodriguez (I)
Olga Lopez (O)
David Ortiz (D)
Nathaly Gonzalez (N)
Angela Gentile (A)
Maria Del Valle Juarez (M)
Aubree Gordon (A)
Clare Cutland (C)
Michelle Groome (M)
Shabir A Madhi (SA)
Marta C Nunes (MC)
Susan Nzenze (S)
Terho Heikkinen (T)
Siddhivinayak Hirve (S)
Sanjay Juvekar (S)
Natasha Halasa (N)
Jorge H Jara (JH)
Chris Bernart (C)
Mark A Katz (MA)
Ilan Gofer (I)
Yonat Shemer Avni (YS)
Najwa Khuri-Bulos (N)
Samir Faori (S)
Asem Shehabi (A)
Anand Krishnan (A)
Rakesh Kumar (R)
Ritvik Amarchand (R)
Carmen L Contreras (CL)
Oscar de Leon (O)
Maria R Lopez (MR)
John P McCracken (JP)
Herberth Maldonado (H)
Antonio P Samayoa (AP)
Ana B Gomez (AB)
Marilla G Lucero (MG)
Leilani T Nillos (LT)
Socorro P Lupisan (SP)
Hanna Nohynek (H)
Ainara Mira-Iglesias (A)
Joan Puig-Barberà (J)
Javier Díez-Domingo (J)
Bradford D Gessner (BD)
Berthe-Marie Njanpop-Lafourcade (BM)
Jennifer C Moïsi (JC)
Haoua Tall (H)
Patrick K Munywoki (PK)
Mwanjuma Ngama (M)
D James Nokes (DJ)
Saad B Omer (SB)
Dayna R Clark (DR)
Millogo Ourohiré (M)
Sié Ali (S)
Zabré Pascal (Z)
Bagagnan H Cheik (BH)
Mauricio T Caballero (MT)
Romina Libster (R)
Fernando P Polack (FP)
Zeba A Rasmussen (ZA)
Elizabeth D Thomas (ED)
Julia M Baker (JM)
Barbara A Rath (BA)
Patrick E Obermeier (PE)
M D Hassanuzzaman (MD)
Maksuda Islam (M)
Mohammad S Islam (MS)
Samir K Saha (SK)
Pinaki Panigrahi (P)
Anuradha Bose (A)
Rita Isaac (R)
David Murdoch (D)
Pritish Nanda (P)
Shamim A Qazi (SA)
Danielle Hessong (D)
Eric Af Simőes (EA)
Viviana Sotomayor (V)
Somsak Thamthitiwat (S)
Malinee Chittaganpitch (M)
Halima Dawood (H)
Catherine Kyobutungi (C)
Marylene Wamukoya (M)
Abdhalah K Ziraba (AK)
Lay-Myint Yoshida (LM)
Keisuke Yoshihara (K)
Duc-Anh Dand (DA)
Minh-Nhat Le (MN)
Mark P Nicol (MP)
Heather J Zar (HJ)
Shobha Broor (S)
Mandeep Chadha (M)
Lola Madrid (L)
Lionel Gresh (L)
Angel Balmaseda (A)
Guillermina Kuan (G)
Niteen Wairagkar (N)
Milagritos D Tapia (MD)
Stacey L Knobler (SL)
Alfredo Barahona (A)
Ericka Ferguson (E)
Brunhilde Schweiger (B)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Références

MMWR Surveill Summ. 2013 Oct 25;62(4):1-28
pubmed: 24157710
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2:105-13
pubmed: 24034494
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S66-S75
pubmed: 28398999
Influenza Other Respir Viruses. 2015 Mar;9(2):85-93
pubmed: 25557920
Western Pac Surveill Response J. 2013 Mar 03;4(3):51-9
pubmed: 24319615
Vaccine. 2016 Oct 26;34(45):5400-5405
pubmed: 27646030
Lancet Respir Med. 2014 Sep;2(9):750-63
pubmed: 25131494
Clin Infect Dis. 2019 Nov 13;69(11):1845-1853
pubmed: 30715278
Am J Epidemiol. 2018 Feb 1;187(2):378-388
pubmed: 28679157
J Glob Health. 2015 Jun;5(1):010408
pubmed: 26445672
Pediatr Infect Dis J. 2018 May;37(5):436-440
pubmed: 29443825
Lancet Glob Health. 2018 Dec;6(12):e1268-e1269
pubmed: 30420025
PLoS One. 2015 Apr 20;10(4):e0126997
pubmed: 25894233
Sci Transl Med. 2013 Jun 26;5(191):191ra84
pubmed: 23803706
Lancet. 2011 Dec 3;378(9807):1917-30
pubmed: 22078723
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Int J Epidemiol. 2012 Jun;41(3):579-88
pubmed: 22798690
Nat Med. 2004 Aug;10(8):811-3
pubmed: 15247911
Vaccine. 2017 Aug 24;35(36):4681-4686
pubmed: 28754488
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Vaccine. 2009 Aug 21;27 Suppl 3:C9-C14
pubmed: 19683658
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Pediatr Infect Dis J. 2015 Jan;34(1):66-72
pubmed: 25093972
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848
Clin Infect Dis. 2018 Jan 6;66(1):95-103
pubmed: 29040527
Croat Med J. 2013 Apr;54(2):122-34
pubmed: 23630140
Clin Infect Dis. 2017 Oct 1;65(7):1066-1071
pubmed: 28575286
JAMA Pediatr. 2016 Sep 1;170(9):840-7
pubmed: 27380464
Lancet Infect Dis. 2016 Sep;16(9):1026-1035
pubmed: 27261067
Hum Vaccin Immunother. 2016 Aug 2;12(8):2206-2214
pubmed: 27196006
Influenza Other Respir Viruses. 2016 Jul;10(4):254-67
pubmed: 26842617
Stat Med. 2010 Dec 20;29(29):3046-67
pubmed: 20827667
Vaccine. 2018 Jan 25;36(4):442-452
pubmed: 29287683
Vaccine. 2014 Nov 12;32(48):6369-76
pubmed: 25442403

Auteurs

Xin Wang (X)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.

You Li (Y)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.

Katherine L O'Brien (KL)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Shabir A Madhi (SA)

Medical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya; Institute of Tropical Medicine, Antwerp, Belgium.

Peter Byass (P)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Saad B Omer (SB)

Yale Institute for Global Health; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Qalab Abbas (Q)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Asad Ali (A)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Alberta Amu (A)

Dodowa Health Research Centre, Dodowa, Ghana.

Eduardo Azziz-Baumgartner (E)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Quique Bassat (Q)

Barcelona Global Health Institute, Hospital Clínic-University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu (University of Barcelona), Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

W Abdullah Brooks (W)

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Sandra S Chaves (SS)

Influenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya.

Alexandria Chung (A)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.

Cheryl Cohen (C)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Marcela Echavarria (M)

Clinical Virology Unit, Centro de Educación Médica e Investigaciones Clínicas, Argentina.

Rodrigo A Fasce (RA)

Public Health Institute of Chile, Región Metropolitana, Chile.

Angela Gentile (A)

Ricardo Gutierrez Children Hospital, Buenos Aires, Argentina.

Aubree Gordon (A)

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Michelle Groome (M)

Medical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Terho Heikkinen (T)

Department of Pediatrics, University of Turku and Turku University Hospital, Finland.

Siddhivinayak Hirve (S)

Vadu Rural Health program, KEM Hospital Research Centre, Pune, Maharashtra, India.

Jorge H Jara (JH)

Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.

Mark A Katz (MA)

Chief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel; Ben Gurion University of the Negev, School of Public Health and Medical School for International Health, Beer-Sheva, Israel; University of Michigan School of Public Health, Ann Arbor, MI, USA.

Najwa Khuri-Bulos (N)

Department of Pediatrics, University of Jordan School of Medicine, Amman, Jordan.

Anand Krishnan (A)

Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Oscar de Leon (O)

Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.

Marilla G Lucero (MG)

ARI Study Group, Research Institute for Tropical Medicine, Muntinlupa, Philippines.

John P McCracken (JP)

Center for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.

Ainara Mira-Iglesias (A)

Área de Investigación en Vacunas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Salud Pública), Valencia, Spain.

Jennifer C Moïsi (JC)

Agence de Médecine Préventive, Paris, France.

Patrick K Munywoki (PK)

KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Millogo Ourohiré (M)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Fernando P Polack (FP)

Fundacion INFANT, Buenos Aires, Argentina.

Manveer Rahi (M)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.

Zeba A Rasmussen (ZA)

Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Barbara A Rath (BA)

Vienna Vaccine Safety Initiative, Berlin, Germany.

Samir K Saha (SK)

Department of Microbiology, Child Health Research Foundation, Dhaka, Bangladesh.

Eric Af Simões (EA)

Department of Pediatrics, Section of Infectious Diseases, University of Colorado, School of Medicine, Aurora, CO, USA; Department of Epidemiology and Center for Global Health, Colorado School of Public Health, Aurora CO, USA.

Viviana Sotomayor (V)

Epidemiology Department, Ministry of Health, Santiago, Chile.

Somsak Thamthitiwat (S)

Division of Global Health Protection, Thailand Ministry of Public Health; US CDC Collaboration, Nonthaburi, Thailand.

Florette K Treurnicht (FK)

Department of Medical Virology, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Marylene Wamukoya (M)

African Population & Health Research Center, Nairobi, Kenya.

Lay-Myint Yoshida (LM)

Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.

Heather J Zar (HJ)

Department of Paediatrics & Child Health and Medical Research Council unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.

Harry Campbell (H)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.

Harish Nair (H)

Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK. Electronic address: harish.nair@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH